Registry of Psoriasis Health Outcomes: A Longitudinal Real-world Collaboration (RePhlect) - A real-world, prospective, observational study of the comparative effectiveness of deucravacitinib in adults with plaque psoriasis in Japa
Not Applicable
- Conditions
- Plaque psoriasis
- Registration Number
- JPRN-UMIN000052957
- Lead Sponsor
- Bristol-Myers Squibb K.K.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 600
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who meet any of the following criteria will be excluded from the study: - Patients currently participating in or planning to participate in an interventional clinical trial - Patients enrolled in DEUC Post Marketing Surveillance (PMS; ClinicalTrial.gov ID: NCT05633264) - Previous treatment experience with the treatment of interest (e.g. patients who have history of APR will not be eligible to be enrolled in APR arm of the study and similar for DEUC)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method